JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109259

Anti-Transferrin Receptor 抗体 [EPR4013]

Anti-Transferrin Receptor antibody [EPR4013]

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Recombinant Monoclonal Transferrin Receptor antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.

查看别名

CD71, Transferrin receptor protein 1, TR, TfR, TfR1, Trfr, T9, p90, TFRC

2 Images
Western blot - Anti-Transferrin Receptor antibody [EPR4013] (AB109259)
  • WB

Unknown

Western blot - Anti-Transferrin Receptor antibody [EPR4013] (AB109259)

All lanes:

Western blot - Anti-Transferrin Receptor antibody [EPR4013] (ab109259) at 1/10000 dilution

Lane 1:

Human placenta lysate at 10 µg

Lane 2:

MCF7 lysate at 10 µg

Lane 3:

JAR lysate at 10 µg

Predicted band size: 84 kDa

Observed band size: 90 kDa

false

Western blot - Anti-Transferrin Receptor antibody [EPR4013] (AB109259)
  • WB

Lab

Western blot - Anti-Transferrin Receptor antibody [EPR4013] (AB109259)

Anti-Transferrin Receptor antibody [EPR4013] staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109259 was shown to bind specifically to Transferrin Receptor. A band was observed at 90 kDa in wild-type K562 cell lysates with no signal observed at this size in Tfrc knockout cell line. To generate this image, wild-type and Tfrc knockout K562 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween$®$ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Transferrin Receptor antibody [EPR4013] (ab109259) at 1/10000 dilution

Lane 1:

Wild-type K562 cell lysate at 20 µg

Lane 2:

Western blot - Human TFRC knockout K562 cell line (<a href='/products/cell-lines/human-tfrc-knockout-k562-cell-line-ab288185'>ab288185</a>)

Lane 2:

TFRC knockout K562 cell lysate at 20 µg

Lane 3:

HDLM-2 cell lysate at 20 µg

Lane 4:

SH-SY5Y cell lysate at 20 µg

Observed band size: 90 kDa

false

不同偶联物与剂型 (1)

  • Carrier free

    Anti-Transferrin Receptor antibody [EPR4013] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR4013

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The transferrin receptor commonly referred to as TfR or CD71 is an integral membrane protein that facilitates the uptake of transferrin-bound iron into cells. This receptor has a molecular weight of around 95 kDa and often exists as a homodimer on the cell surface. It is widely expressed in many tissues especially in erythroid precursors and rapidly dividing cells. Alternate names for this receptor include TfR1 and TfR2 though they have distinct roles and distributions. Other transmembrane proteins like OX26 and MEM have been studied in relation to the transferrin receptor due to their involvement in drug delivery.
Biological function summary

TfR plays a critical role in iron homeostasis by mediating the internalization of transferrin and release of iron in the endosomes. It operates as part of the transferrin-transferrin receptor complex facilitating iron assimilation necessary for DNA synthesis and cell growth. Iron release involves acidifying endosomes allowing transferrin to bind with specific cellular receptors including alternate forms like beta 2 transferrin. The process subsequently contributes to erythropoiesis and various metabolic processes by regulating essential cellular iron levels.

Pathways

The transferrin receptor is central to iron metabolism and the receptor-mediated endocytosis pathway. It tightly interacts with transferrin and intracellular pathways process the iron released from transferrin within endosomes. The receptor's role in this pathway involves a dynamic with other proteins such as HFE and hepcidin. These interactions help control systemic iron levels linking closely to the maintenance of erythroid cell health and proliferation.

Disruptions in transferrin receptor function correlate with anemia and neurodegenerative disorders. In anemia related to iron deficiency impaired TfR activity reduces iron uptake culminating in insufficient erythropoiesis. Altered receptor expression or function also connects to neurological diseases like Alzheimer's where iron dysregulation is a concern. Here the transferrin receptor interacts with proteins like Amyloid precursor protein contributing to disease pathology through improper metal homeostasis.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

The protein expressed by the gene TFRC is involved in the cellular uptake of iron via receptor-mediated endocytosis, where the transferrin receptor, bound to its ligand, is internalized into specialized endosomes. Following endosomal acidification, iron is released, and the apotransferrin-receptor complex is recycled to the cell surface, where a return to neutral pH results in the loss of apotransferrin's affinity for its receptor. The hereditary hemochromatosis protein HFE competes with transferrin for binding at an overlapping C-terminal site. TFRC positively regulates T and B cell proliferation through iron uptake. It functions as a lipid sensor influencing mitochondrial fusion by modulating the JNK pathway activity. Low dietary levels of stearate promote JNK pathway activation, leading to HUWE1-mediated ubiquitination and degradation of the mitofusin MFN2, inhibiting mitochondrial fusion. High dietary stearate levels result in TFRC stearoylation, which inhibits JNK pathway activation and MFN2 degradation. Additionally, TFRC acts as a receptor for new-world arenaviruses, including Guanarito, Junin, and Machupo viruses. This supplementary information is collated from multiple sources and compiled automatically.
See full target information TFRC

文献 (4)

Recent publications for all applications. Explore the full list and refine your search

Journal of cellular and molecular medicine 29:e70609 PubMed40394754

2025

Erk1/2 Orchestrates SSPH I-Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yuewen Sun,Ying Zhou,Dan Huang,Zhiguang Zhao,Qingrui Shao,Jianzhe Li,Xiaofang Zhao,Xudong Liu

Molecular medicine reports 30: PubMed39370816

2024

ETV4‑mediated transcriptional activation of SLC12A5 exacerbates ferroptosis resistance and glucose metabolism reprogramming in breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wang,Yanyan Dai,Fengxiang Wang

Redox biology 72:103157 PubMed38631119

2024

Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Lin Wu,Yuxin Du,Litao Wang,Yingmei Zhang,Jun Ren

The Journal of biological chemistry 293:3421-3435 PubMed29317492

2018

A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Mahmood Faraz,Carl Herdenberg,Camilla Holmlund,Roger Henriksson,Håkan Hedman
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com